These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21392983)

  • 1. 1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action.
    Ray R; Lambert JR
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2537-40. PubMed ID: 21392983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha,25-dihydroxyvitamin D3 to calcitroic acid.
    Sakaki T; Sawada N; Nonaka Y; Ohyama Y; Inouye K
    Eur J Biochem; 1999 May; 262(1):43-8. PubMed ID: 10231362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells.
    Sundaram S; Beckman MJ; Bajwa A; Wei J; Smith KM; Posner GH; Gewirtz DA
    Mol Cancer Ther; 2006 Nov; 5(11):2806-14. PubMed ID: 17121927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1alpha,25-dihydroxyvitamin D3.
    Miyamoto Y; Shinki T; Yamamoto K; Ohyama Y; Iwasaki H; Hosotani R; Kasama T; Takayama H; Yamada S; Suda T
    J Biol Chem; 1997 May; 272(22):14115-9. PubMed ID: 9162038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
    Iglesias-Gato D; Zheng S; Flanagan JN; Jiang L; Kittaka A; Sakaki T; Yamamoto K; Itoh T; Lebrasseur NK; Norstedt G; Chen TC
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):269-75. PubMed ID: 21911059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation.
    Posner GH; Lee JK; Wang Q; Peleg S; Burke M; Brem H; Dolan P; Kensler TW
    J Med Chem; 1998 Jul; 41(16):3008-14. PubMed ID: 9685240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D(3)-26, 23-lactone analogs on 25-hydroxyvitamin-D(3)-24-hydroxylase gene expression induced by 1alpha,25-dihydroxy-vitamin D(3) in human promyelocytic leukemia (HL-60) cells.
    Ishizuka S; Miura D; Eguchi H; Ozono K; Chokki M; Kamimura T; Norman AW
    Arch Biochem Biophys; 2000 Aug; 380(1):92-102. PubMed ID: 10900137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
    Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
    J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 26,26,26,27,27,27-F6-1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
    Sakaki T; Sawada N; Abe D; Komai K; Shiozawa S; Nonaka Y; Nakagawa K; Okano T; Ohta M; Inouye K
    Biochem Pharmacol; 2003 Jun; 65(12):1957-65. PubMed ID: 12787875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
    Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells.
    Peng X; Tiwari N; Roy S; Yuan L; Murillo G; Mehta RR; Benya RV; Mehta RG
    J Endocrinol; 2012 Feb; 212(2):207-15. PubMed ID: 22068926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.
    Jones G; Byford V; West S; Masuda S; Ibrahim G; Kaufmann M; Knutson JC; Strugnell S; Mehta R
    Anticancer Res; 2006; 26(4A):2589-95. PubMed ID: 16886668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells.
    Zhang Q; Kanterewicz B; Buch S; Petkovich M; Parise R; Beumer J; Lin Y; Diergaarde B; Hershberger PA
    Mol Cell Endocrinol; 2012 May; 355(1):153-61. PubMed ID: 22386975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
    Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
    Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 20-epimer of 1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
    Kusudo T; Sakaki T; Abe D; Fujishima T; Kittaka A; Takayama H; Ohta M; Inouye K
    Biochem Biophys Res Commun; 2003 Oct; 309(4):885-92. PubMed ID: 13679056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D--metabolism in the human breast cancer cell line MCF-7.
    Diesing D; Cordes T; Fischer D; Diedrich K; Friedrich M
    Anticancer Res; 2006; 26(4A):2755-9. PubMed ID: 16886688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
    Roy S; Martel J; Tenenhouse HS
    J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.